Sort by
Keyphrases
Influenza Virus
100%
Drug Candidates
100%
Neuraminidase
100%
Computational Design
100%
Virus Subtypes
100%
Viral Neuraminidase
100%
Subtype H1N1
100%
Cysteine
66%
Arginine
50%
Proline
50%
Tyrosine
33%
Methionine
33%
Cyclization
33%
Cystein
33%
Molecular Docking
16%
Binding Energy
16%
Hydrogen Bonding Interaction
16%
Molecular Dynamics
16%
Potential Alternatives
16%
High Specificity
16%
Protease Enzyme
16%
High Activity
16%
Digestion
16%
Oral Bioavailability
16%
Potential Inhibitors
16%
Computational Methods
16%
Ligand-receptor Binding
16%
Polypeptide
16%
Disulfide Bridge
16%
Peptide Ligand
16%
Phenylalanine
16%
Residual Interaction
16%
Dynamic Progress
16%
Peptide Drug Design
16%
Peptide Stability
16%
H1N1 Infection
16%
Biochemistry, Genetics and Molecular Biology
Enzyme
100%
Influenza A Virus (H1N1)
100%
Viral Neuraminidase
100%
Cysteine
100%
Sialidase
83%
Neuraminidase
83%
Arginine
50%
Proline
50%
Dynamics
33%
Tyrosine
33%
Methionine
33%
Docking (Molecular)
16%
Binding Energy
16%
Disulfide
16%
Peptide Stability
16%
Protease
16%
Phenylalanine
16%
Receptor Binding
16%
Pharmacology, Toxicology and Pharmaceutical Science
Influenza A Virus (H1N1)
100%
Cysteine
100%
Sialidase
100%
Arginine
50%
Proline
50%
Methionine
33%
Receptor
16%
Infection
16%
Drug Development
16%
Bioavailability
16%
Proteinase
16%
Disulfide
16%
Phenylalanine
16%
Polypeptide
16%
Peptide Stability
16%
Material Science
Cysteine
100%
Arginine
75%
Proline
75%
Tyrosine
50%
Methionine
50%
Hydrogen Bonding
25%
Phenylalanine
25%
Peptide Stability
25%
Chemistry
Cysteine
100%
Proline
50%
Arginine
50%
Methionine
33%
Hydrogen Bonding
16%
Molecular Dynamics
16%
Carcinogenic
16%
Binding Energy
16%
Bioavailability
16%
Disulfide
16%
formation
16%
mutagenic
16%
Peptide Stability
16%
Phenylalanine
16%
Polypeptide
16%